Today we announced the construction of two new radioligand therapy (RLT) manufacturing facilities, one of which will produce critical isotopes necessary to create these medicines. As the leader in RLT development and delivery, we remain committed to pioneering RLT science and broadening manufacturing capabilities to support the growing demand for this novel approach to cancer care.
Novartis US
Pharmaceutical Manufacturing
East Hanover, New Jersey 91,308 followers
Transforming people’s lives by reimagining medicine.
About us
At Novartis US, our mission is to reimagine medicine and discover new ways to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. Novartis products reach nearly 800 million people globally and we are finding innovative ways to provide solutions to address the evolving needs of patients. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Over 41% of global Novartis R&D expenditure ($3.9 billion) was invested in the US in 2019. Our US presence is comprised of nearly 15,000 employees, with campuses across the country including in East Hanover, NJ, Cambridge, MA, and Indianapolis, IN. See our community guidelines: http://bit.ly/2JnT2CP
- Website
-
https://www.novartis.us/
External link for Novartis US
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- East Hanover, New Jersey
- Founded
- 1996
- Specialties
- Research, Innovation, Quality, Sustainability, Innovative Medicines, Generic Medicines and Biosimilars, Unique Portfolio Focuses & Broad Healthcare Portfolio, Cell & Gene Therapy, and Data & Digital
Updates
-
We are honored to be a nominee for the 2024 #PrixGalien USA Award within the Best Pharmaceutical Product category. Thank you to The Galien Foundation for recognizing the potential of #radioligandtherapy (RLT). We are committed to the present—and the future—of RLT as we continue #reimaginingmedicine, together.
The Galien Foundation is delighted to announce the 2024 #PrixGalien USA Award nominees for “Best Biotechnology Product," "Best Pharmaceutical Product", and "Best Product for Rare/Orphan Diseases", ahead of the prestigious #PrixGalien Awards Ceremony at the American Museum of Natural History, in New York. For the full list of nominees, please visit: https://galien.org/3ytYhgP
-
Today’s FDA accelerated approval of a new therapy for appropriate adults with primary IgA nephropathy (IgAN) marks an important milestone in our ambition to help transform outcomes for people living with rare kidney diseases. #IgAN #IgANephropathy #KidneyDisease
-
We are proud to be recognized as a “Best Place to Work for Disability Inclusion” by Disability:IN for the third consecutive year, earning a top score of 100 on the Disability Equality Index (DEI). This recognition underlines our commitment to fostering an inclusive culture and society that not only accepts but also celebrates diversity and inclusion. We know there's always more work to do and we will continue building on our efforts to make our workplaces even more inclusive. #NovartisUS #Diversity #Inclusion #AreYouIN #BestPlaceToWork24 Learn more about the index and criteria here: https://lnkd.in/g8Hmbvc9
-
-
As we welcome the summer season, we recently celebrated with a company-wide picnic on our East Hanover campus. It was a colorful day filled with activities, good food, and connections. Besides being a great way to connect with our colleagues, the picnic also served as a gentle reminder of the value of taking a break. As we step into the break we want to reassure our team members about the importance of relaxing, rejuvenating, and taking time to enjoy life outside of work. As we advocate for health in every capacity, we encourage our team members to make use of their summer break to recharge and spend quality time with family and friends. Rest is critical to continue our shared mission of improving and extending people's lives. #ReimaginingMedicine #Summer
-
-
This year marked Novartis' 5th annual Day of Reflection, themed "Health Equity: Compassion, Purpose & Advocacy into Action.” In line with our commitment to improving patients' lives, we heard from people representing many community voices and explored patient population issues in partnership with BlackDoctor.org, emphasizing holistic healthcare for all. Our associates engaged with a diverse range of expert healthcare advocates including our keynote speaker, Stephen Trzeciak, MD, a practicing specialist, clinical researcher, and author of “Compassionomics,” Novartis leaders and patients who are using their experiences to advocate for change. These important conversations lead to ways that we apply our learnings in the work we do each day. It is so incredibly important to continue to amplify the voices of all communities in our journey to reimagine medicine. Victoria Marie Reese Tara Robinson M.ED Frank Rivera Lyndsay Levingston Joel Bervell #Novartistogether #DayofReflection #EmbracingEquity
-
-
-
-
-
+2
-
-
What’s it like attending ASCO as a Novartis team member? Come along with us as we recap some of our favorite moments from #ASCO24 Vas Narasimhan Victor Bultó Reshema Kemps-Polanco
-
Multiple sclerosis (MS) affects nearly 3 million people worldwide and 1 million here in the U.S. This past week our team attended the Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, where we collaborated with patient advocacy groups, including MS Views and News and Can Do MS, to facilitate important MS education programs to assist people living with MS and their care partners. We’d like to extend our thanks to all of the patient organizations for their engagement and tireless dedication to the MS community. We remain committed to our trusted partnerships, and to understanding and solving some of the most burdensome neurological conditions to improve the quality of life for patients and their caregivers. #CMSC2024
-
-
-
-
-
+3
-
-
Our big takeaway from #ASCO24 – we are part of a collective effort to transform cancer care. What will future treatment for cancer look like? As we #Reimaginemedicine together with advocacy groups and healthcare professionals, we believe in the promise of #Radioligandtherapy (RLT) and are exploring ways that collaboration can bring innovation to all aspects of RLT for patients worldwide. https://lnkd.in/gSZnfTqJ
-
-
When communities collaborate, that’s when patients win. Bringing together experts at the Chronic Myeloid Leukemia (#CML) Patient Advocate and Medical Expert Leadership Summit at #ASCO2024 sparked a journey to #reimaginemedicine together for patients living with this #bloodcancer. Thank you to our participants for joining us and embracing this time together to address gaps and support CML patients.
-